The pace of biomedical innovation continues to accelerate, with Immunological advances leading the way in shaping how new treatments, therapies and cures can be achieved. This exciting progress has not escaped the attention of IMMpress Magazine, which again dedicates an issue to understanding and exploring Innovation & Commercialization.
As we have come to expect, this issue has brilliant and well research articles on clinical trial development and regulatory hurdles, new drugs for orphan diseases, and the utilization of social media in trials. The development of novel biomarkers, biologic versus small molecule drugs, and the problem of antibiotic resistance are deftly discussed. This issue also focuses on innovation in Toronto, including as part of the alumni interview with Dr. Patrycja Thompson. As in previous years, IMMpress participated in the annual meeting of the Canadian Society for Immunology (CSI), and provide a wonderful set of conference highlights, in case you missed making it to Banff or simply need a refresher.
This issue of IMMpress Magazine marks the start of Yoojin Choi (Kaul lab) as co-Editor in-Chief, who along with Dario Ferri (Wither lab) have put together another compelling and forward-looking issue for us. I would like to thank Dario for his leadership and determined dedication as co-editor in chief over the past 2 volumes, which delved in and featured thoughtful and provocative topics. I look forward to welcoming Pailin Chiaranunt (Mortha lab), who will join Yoojin, as co-Editor-in-Chief of the magazine.
I am also delighted to announce that Department of Immunology Strategic Plan 2019-2023 has been released, and can be accessed at our departmental website, under the About Us tab, along with the previous and initial plan for 2014-2018. You can read about all the new and exciting new initiatives that will further enhance our academic and research training mission.
I hope you enjoy this issue, make it part of your late summer reading, and importantly whether you are an alumnus of the department, or a prospective student, I really look forward to hearing from you.